
The Nagoya Protocol on ‘Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization (ABS)’ represented a deep transformation on the discovery and use of new enzymes from nature since 2014.
The recent COP16 decision to adopt the necessary arrangements for the fair and equitable sharing of benefits arising from the use of DSI on genetic resources (see
https://www.cbd.int/doc/decisions/cop-16/cop-16-dec-02-en.pdf) will undoubtedly impact academic and industrial research and innovation on microbiomes and biocatalysis, in which databases are often mined to find novel enzymes and biosynthetic pathways but also to develop computational tools.
This workshop seeks to inform researchers on microbiome and biocatalysis about the recent agreements regarding benefit sharing for DSI and features different academic and industrial stakeholders. The aim is to reflect on >10 years of ABS and on the expectations for the new paradigm around DSI.